Loading
Life sciences · Journal article
Cell Insight · September 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Aging increases susceptibility to severe viral infection, weakens vaccine responses, promotes chronic inflammatory disease, and alters tumor immune surveillance. These outcomes reflect not a simple loss of immune activity, but age-associated remodeling of the amplitude, kinetics, and resolution of innate immune responses. In aged tissues, nucleic acid-sensing pathways often display elevated basal inflammatory or antiviral-like signaling, whereas inducible type I interferon (IFN) and interferon-stimulated gene (ISG) responses to infection or vaccination are delayed, blunted, or poorly resolved. This review summarizes the innate antiviral signaling pathways and discusses how aging and cellular senescence narrow the range between basal and inducible responses. We emphasize senescent cells as sources of senescence-associated secretory phenotype (SASP) factors that suppress neighboring-cell antiviral IFN responses and amplify inflammatory tissue damage, and discuss strategies to restore inducible IFN competence while limiting chronic basal activation in older adults, to improve vaccine efficacy and treat aging-associated infectious diseases.